{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:39:05Z","timestamp":1758587945244,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.therap.2020.06.016","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T18:35:01Z","timestamp":1594319701000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analyse des modifications de statut r\u00e9glementaire des m\u00e9dicaments en France\u00a0: 2010\u20132019"],"prefix":"10.1016","volume":"76","author":[{"given":"Marie","family":"Castani\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Juillard-Condat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Galian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Giroud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Article L.\u00a05111-1\u00a0du Code de la sant\u00e9 publique","key":"10.1016\/j.therap.2020.06.016_bib0160"},{"year":"2020","series-title":"Article L.\u00a05211-1\u00a0du Code de la sant\u00e9 publique","key":"10.1016\/j.therap.2020.06.016_bib0165"},{"year":"2020","series-title":"Article L.\u00a05131-1\u00a0du Code de la sant\u00e9 publique","key":"10.1016\/j.therap.2020.06.016_bib0170"},{"year":"2007","series-title":"R\u00e8glement (CE) 1924\/2006\u00a0du parlement europ\u00e9en et du conseil du 20\u00a0d\u00e9cembre 2006\u00a0concernant les all\u00e9gations nutritionnelles et de sant\u00e9 portant sur les denr\u00e9es alimentaires","key":"10.1016\/j.therap.2020.06.016_bib0175"},{"year":"2012","series-title":"Article L.\u00a05121-8\u00a0du Code de la sant\u00e9 publique","key":"10.1016\/j.therap.2020.06.016_bib0180"},{"year":"2018","series-title":"Article L.\u00a05211-3\u00a0du Code de la sant\u00e9 publique","key":"10.1016\/j.therap.2020.06.016_bib0185"},{"year":"2009","series-title":"R\u00e8glement (CE) 1223\/2009\u00a0du Parlement europ\u00e9en et du Conseil du 30\u00a0novembre 2009\u00a0relatif aux produits cosm\u00e9tiques, Article 13","key":"10.1016\/j.therap.2020.06.016_bib0190"},{"year":"2006","series-title":"D\u00e9cret no\u00a02006-352\u00a0du 20\u00a0mars 2006\u00a0relatif aux compl\u00e9ments alimentaires","key":"10.1016\/j.therap.2020.06.016_bib0195"},{"year":"2019","series-title":"Les statuts des produits de sant\u00e9\u00a0: porosit\u00e9 des fronti\u00e8res et changements multiples","author":"Castani\u00e9","key":"10.1016\/j.therap.2020.06.016_bib0200"},{"year":"2020","series-title":"EurekaSant\u00e9 Vidal","key":"10.1016\/j.therap.2020.06.016_bib0205"},{"year":"2020","series-title":"Sant\u00e9 LeFigaro","key":"10.1016\/j.therap.2020.06.016_bib0210"},{"key":"10.1016\/j.therap.2020.06.016_bib0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3917\/dsso.032.0051","article-title":"Aper\u00e7u de l\u2019activit\u00e9 jurisprudentielle de la CJUE en mati\u00e8re de produits de sant\u00e9","volume":"2\u20133","author":"Espesson-Vergeat","year":"2016","journal-title":"Droit Sante Societe"},{"key":"10.1016\/j.therap.2020.06.016_bib0220","first-page":"21","article-title":"Le m\u00e9dicament\u00a0: retour sur une qualification en d\u00e9bat","volume":"21","author":"Laigneau","year":"2015","journal-title":"RGDM"},{"issue":"41","key":"10.1016\/j.therap.2020.06.016_bib0225","first-page":"11","article-title":"Focus\u00a0: aux fronti\u00e8res du dispositif m\u00e9dical et du m\u00e9dicament","volume":"4","author":"Kastler","year":"2013","journal-title":"Tribunes Sante"},{"key":"10.1016\/j.therap.2020.06.016_bib0230","first-page":"39","article-title":"Compl\u00e9ments alimentaires \u00e0 base de m\u00e9latonine\u00a0: la qualification de m\u00e9dicament est retenue en fonction du dosage","volume":"21","author":"Chamot","year":"2015","journal-title":"RGDM"},{"key":"10.1016\/j.therap.2020.06.016_bib0235","first-page":"97","article-title":"Qu\u2019est-ce qu\u2019un cosm\u00e9tique\u00a0? Qu\u2019appelle-t-on produits fronti\u00e8res\u00a0?","volume":"406","author":"Couteau","year":"2010","journal-title":"Bull Ordre Natl Pharm"},{"year":"2016","author":"Agence nationale de s\u00e9curit\u00e9 des m\u00e9dicaments et des produits de sant\u00e9 (ANSM)","key":"10.1016\/j.therap.2020.06.016_bib0240"},{"year":"2010","series-title":"La \u00ab\u00a0jungle\u00a0\u00bb des statuts des produits fronti\u00e8res autour du m\u00e9dicament\u00a0: illustrations et analyse","author":"Caldato","key":"10.1016\/j.therap.2020.06.016_bib0245"},{"year":"2012","series-title":"Les produits fronti\u00e8res\u00a0: r\u00e9flexion autour de l\u2019attribution d\u2019un statut r\u00e9glementaire","author":"Casado","key":"10.1016\/j.therap.2020.06.016_bib0250"},{"year":"2017","series-title":"Les produits fronti\u00e8res entre m\u00e9dicament et compl\u00e9ment alimentaire\u00a0: cadre juridique et illustrations","author":"Hasquenoph","key":"10.1016\/j.therap.2020.06.016_bib0255"},{"issue":"55","key":"10.1016\/j.therap.2020.06.016_bib0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3917\/seve.055.0029","article-title":"Les produits fronti\u00e8res","volume":"2","author":"Homobono","year":"2017","journal-title":"Tribunes Sante"},{"year":"2020","series-title":"Le d\u00e9remboursement des m\u00e9dicaments en France entre 2002\u00a0et 2010\u00a0: \u00e9l\u00e9ments d\u2019\u00e9valuation. Questions d\u2019\u00e9conomie de la sant\u00e9 2011:167","author":"Pichetti","key":"10.1016\/j.therap.2020.06.016_bib0265"},{"year":"2018","series-title":"\u00ab\u00a0Les compl\u00e9ments alimentaires contenant des plantes\u00a0\u00bb","author":"Acad\u00e9mie nationale de Pharmacie","key":"10.1016\/j.therap.2020.06.016_bib0270"},{"year":"2017","series-title":"Troisi\u00e8me \u00e9tude individuelle nationale des consommations alimentaires","author":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES)","key":"10.1016\/j.therap.2020.06.016_bib0275"},{"year":"2018","series-title":"T\u00e9l\u00e9d\u00e9claration de mise sur le march\u00e9 des compl\u00e9ments alimentaires, bilan de l\u2019ann\u00e9e 2017","author":"Direction g\u00e9n\u00e9rale de la concurrence, de la consommation et de la r\u00e9pression des fraudes (DGCCRF)","key":"10.1016\/j.therap.2020.06.016_bib0280"},{"year":"2017","series-title":"Le portail des minist\u00e8res \u00c9conomiques et Financiers. Contr\u00f4le des compl\u00e9ments alimentaires \u00e0 vis\u00e9e articulaire","author":"Direction g\u00e9n\u00e9rale de la concurrence, de la consommation et de la r\u00e9pression des fraudes (DGCCRF)","key":"10.1016\/j.therap.2020.06.016_bib0285"},{"year":"2016","series-title":"Le portail des minist\u00e8res \u00e9conomiques et financiers. Les all\u00e9gations de sant\u00e9 sur les sites Internet de compl\u00e9ments alimentaires","author":"Direction g\u00e9n\u00e9rale de la concurrence, de la consommation et de la r\u00e9pression des fraudes (DGCCRF)","key":"10.1016\/j.therap.2020.06.016_bib0290"},{"year":"2018","series-title":"Avis relatif aux risques li\u00e9s \u00e0 la consommation de compl\u00e9ments alimentaires contenant de la m\u00e9latonine","author":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES)","key":"10.1016\/j.therap.2020.06.016_bib0295"},{"year":"2014","series-title":"Compl\u00e9ments alimentaires \u00e0 base de levure de riz rouge\u00a0: avant consommation, prenez conseil aupr\u00e8s d\u2019un professionnel de sant\u00e9","author":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES)","key":"10.1016\/j.therap.2020.06.016_bib0300"},{"year":"2019","series-title":"Certains compl\u00e9ments alimentaires \u00e0 vis\u00e9e articulaire d\u00e9conseill\u00e9s aux populations \u00e0 risque","author":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES)","key":"10.1016\/j.therap.2020.06.016_bib0305"},{"year":"2019","series-title":"Bilan de nutrivigilance de l\u2019ann\u00e9e 2017","author":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES)","key":"10.1016\/j.therap.2020.06.016_bib0310"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595720301232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595720301232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:53:48Z","timestamp":1758567228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595720301232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0040595720301232"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2020.06.016","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyse des modifications de statut r\u00e9glementaire des m\u00e9dicaments en France\u00a0: 2010\u20132019","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2020.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}